Seeking Alpha

Emisphere Technologies (EMIS)

()

Instablog posts on EMIS

  • The Most Undervalued Biotech by Joseph Ramelli
    The FDA's clinicaltrials.gov website has some really interesting information on the European Phase III trial of Emisphere’s(EMIS) Oral Salmon Calcitonin for Osteoarthritis that is being run by Nordic Bioscience for Emisphere’s partner Novartis(NVS).  Here is a link:... More »
    September 29, 2009 • EMIS, NVS
  • Three Recent Biotechnology Activist Wins by Carl Icahn by Michael Becker
    Although a controversial topic, activist hedge funds and private equity firms typically use a small equity stake in an underperforming company to put public pressure on its management and board of directors with the goal of increasing stakeholder value through cost cutting, changes in corporate... More »
    August 30, 2009 • ALKS, AMLN, AZN
  • Emisphere: The Story Just Got Bigger. by Joseph Ramelli
    There has been a huge positive development in the Emisphere story that hasn’t really filtered out yet. A friend stumbled upon a patent application filed by Novartis entitled “Use of Calcitonin for the Treatment of Rheumatoid Arthritis.” The patent application can be... More »
    June 30, 2009 • EMIS
  • Emisphere (NASDAQ:EMIS): Improving Drug Delivery by Mike Havrilla
    Emisphere (NASDAQ:EMIS) is an emerging bio-pharma company specializing in the development of a drug delivery technology platform for the oral administration of therapeutic compounds which are either poorly absorbed or must be given through alternative routes such as injections. On 6/1/09,... More »
    June 4, 2009 • EMIS, NVS, PRX
  • Straight to the Moon, EMIS! by Joseph Ramelli
     We recently finished buying a position in Emisphere.  We have done a ton of due diligence and networked with some of the smartest biotech minds on the street and think that the stock should be trading at $5 now and that it will be well above $50 within a couple years.  ... More »
    May 15, 2009 • EMIS

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.